Cardium Therapeutics (CXM)
Cardium Therapeutics Fundamental Score
View CXM Fundamental Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CXM Fundamental Score Range, Past 5 Years
| Minimum | 2.00 | Dec 2008 |
| Maximum | 5.00 | Mar 2010 |
| Average | 3.583 |
About Fundamental Score
The fundamental score is YCharts proprietary score of how strong a company's fundamentals are. It ranges from 1 to 10, with 10 being the strongest. The ten tests are as follows (score one point for each test the company passes):
1) EPS Growth > 0
2) Revenue Growth > 0
3) Five Year Average ROE > 5%
4) 10 Year Minimum Gross Margin > 0
5) Book Value Per Share Growth > 0
6) Current Ratio > 1
7) Debt to Equity Ratio < 13
8) 10 Year Average Cash Flow > 0
9) Long Term Debt < 5 x Net Income
10) Uninterrupted dividend payments as far back as we have data
(unless otherwise noted, growth rates are calculated for 10 years or the life of the stock, whichever is shorter)
Further details can be found in our support center article about the fundamental score.
Learn More
You may also be interested in these CXM related companies
CXM News
$CXM Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System http://stks.co/3yJh
about 4 days ago by OTCShowcase
about 4 days ago by OTCShowcase
Cardium Therapeutics (CXM) Enters Excellagen Agreement with Angel Biomedical
May 15, 9:09AM Street Insider
May 15, 9:09AM Street Insider
Cardium Presents First Quarter 2012 Financial Results and Recent Developments
May 15, 9:00AM PR Newswire
May 15, 9:00AM PR Newswire
$CXM Growing Footprint in Health Sciences and Regenerative Medicine Space http://stks.co/3nJI
about 17 days ago by MissionIR
about 17 days ago by MissionIR
Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System
May 11, 8:20AM Marketwire
May 11, 8:20AM Marketwire
Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
Apr 19, 6:43PM PR Newswire
Apr 19, 6:43PM PR Newswire
Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™
Apr 02, 8:00AM PR Newswire
Apr 02, 8:00AM PR Newswire
Cardium Presents Fourth Quarter and Year-End 2011 Financial Results and Recent Developments
Mar 30, 9:15AM PR Newswire
Mar 30, 9:15AM PR Newswire
FAST Act to Modernize Approval Process -- Cardium and BioSante Poised to Benefit
Mar 19, 8:20AM Marketwire
Mar 19, 8:20AM Marketwire
Cardium Presents New Generx Findings at 2012 Annual Gene and Cell Therapy Forum
Jan 30, 9:00AM PR Newswire
Jan 30, 9:00AM PR Newswire
Biotechnology Industry on the Upswing - BioSante and Cardium Therapeutics Look to Rally
Jan 17, 8:20AM Marketwire
Jan 17, 8:20AM Marketwire
Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines
Jan 03, 9:01AM Benzinga
Jan 03, 9:01AM Benzinga
Cardium Therapeutics (CXM) Enters Into Cross-Strategic Equity Investment Partnership with SourceOne Global Partners
Dec 21, 9:23AM Street Insider
Dec 21, 9:23AM Street Insider
$CXM heavy premarket volume, potential FDA approval would be nice way to finish year
about 517 days ago by CaptainOyama
about 517 days ago by CaptainOyama
$SPY trending higher. Check out $CXM FDA approval coming 12/31 this stock trades at .48 will go to $2 or more on approval.
about 522 days ago by scottheggs
about 522 days ago by scottheggs
What to look forward to June 2010 for investors? $CXM, $HNAB, $DCTH, $QCOR http://goo.gl/fb/GuP5p #europecrisis
about 728 days ago by comparebroker
about 728 days ago by comparebroker
$CXM filled the gap.support at .58. first target .87, next stop 1.03. hope to see u all there.
about 766 days ago by StockTA888
about 766 days ago by StockTA888
but will consider buying in the .40s in $CXM, if it gets back down there.
about 768 days ago by LitheLyricist
about 768 days ago by LitheLyricist
buying programs chewing through offers in $CXM. A big offer is left at .55. Risk/reward not good enough to pay .55, probably
about 768 days ago by LitheLyricist
about 768 days ago by LitheLyricist
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CXM | 0.2375 | -0.00 | -0.25% | 28.41M |
| CXH | 10.60 | +0.00 | +0.00% | |
| CXDC | 4.93 | -0.05 | -1.00% | 234.32M |
| CXA | 24.42 | +0.02 | +0.08% | |
| CX | 5.47 | +0.00 | +0.00% | 5.797B |
| CWTR | 0.84 | +0.02 | +2.44% | 102.15M |
| CVS | 44.98 | -0.19 | -0.42% | 58.77B |
| CVRT | 21.71 | +0.00 | +0.00% | |
| CVR | 18.70 | -0.07 | -0.37% | 18.14M |
| CVO | 1.72 | +0.02 | +1.18% | 109.10M |
